| Literature DB >> 30510366 |
Adriana Vaz Safatle-Ribeiro1, Elisa Ryoka Baba1, Rodrigo Corsato Scomparin1, Sheila Friedrich Faraj1, Marcelo Simas de Lima1, Luciano Lenz1, Bruno Costa Martins1, Carla Gusmon1, Fábio Shiguehissa Kawaguti1, Caterina Pennacchi1, Bruno Zilberstein1, Ulysses Ribeiro1, Fauze Maluf-Filho1.
Abstract
OBJECTIVE: Probe-based confocal laser endomicroscopy (pCLE) technique may improve the diagnosis of gastric mucosal lesions allowing acquisition of high-resolution in vivo images at the cellular and microvascular levels. This study aims to evaluate the accuracy of pCLE for the differential diagnosis of non-neoplastic and neoplastic gastric lesions.Entities:
Keywords: Probe-based confocal endomicroscopy; atrophy; endoscopic resection; gastric adenoma; gastric cancer; intestinal metaplasia
Year: 2018 PMID: 30510366 PMCID: PMC6232359 DOI: 10.21147/j.issn.1000-9604.2018.05.08
Source DB: PubMed Journal: Chin J Cancer Res ISSN: 1000-9604 Impact factor: 5.087
5Endoscopic images of 0−IIa + IIb gastric body lesion in 82-year-old male with atrophic gastritis. (A) White-light endoscopy; (B) Probe-based confocal laser endomicroscopy (pCLE) image demonstrates architectural complexity of the glands (budding, clusters of compact back-to-back glands within the interstitium) with severe cell irregularity; (C) Histology shows well differentiated adenocarcinoma [hematoxylin and eosin stain (H&E), ×150].
Demographic data and pCLE indications (N=10)
| Variable | n (%) |
| pCLE, probe-based confocal laser endomicroscopy. | |
| Gender | |
| Male | 6 (60) |
| Female | 4 (40) |
| Age (year) | |
| Mean (range) | 68.3 (42–83) |
| pCLE indications | |
| Gastric elevated lesion | 5 (50) |
| Suspicious early neoplasia | 3 (30) |
| Lymphoma | 1 (10) |
| Post Billroth II gastrectomy | 1 (10) |
pCLE and final histopathological results in 10 patients with gastric lesions
| Patients | Lesions | Size (mm) | Location | Paris | Confocal | Histology |
| pCLE, probe-based confocal laser endomicroscopy; *, Billroth II gastrectomy; **, post chemotherapy lymphoma treatment; ***, cirrhotic patient. | ||||||
| 1 | 1 | 20 | Body | 0−IIa + IIc | Adenoma | Low-grade adenoma |
| 2 | 2 | Body* | Intestinal metaplasia | Intestinal metaplasia + atrophy | ||
| 3 | Body* | Xanthomas | Xanthomas | |||
| 3 | 4 | 8 | Incisura | 0−Is | Intestinal metaplasia | Erosion + intestinal metaplasia |
| 5 | 10 | Distal body | 0−Is | Adenoma | Low-grade adenoma | |
| 6 | 8 | Proximal antrum | 0−Is | Adenoma | Low-grade adenoma | |
| 7 | 17 | Distal antrum | 0−IIa | Adenoma | High-grade adenoma | |
| 8 | 25 | Antrum | 0−IIa | Adenoma | Low-grade adenoma | |
| 4 | 9 | 12 | Body | 0−IIa | Neoplasia | Well differentiated adenocarcinoma |
| 10 | Body | Atrophy | Atrophy | |||
| 5 | 11 | Body | Intestinal metaplasia | Atrophy + intestinal metaplasia | ||
| 12 | 14 | Body | 0−IIa | Adenoma | Low-grade adenoma | |
| 13 | 5 | Antrum | 0−IIa | Adenoma | Intestinal metaplasia | |
| 14 | 10 | Antrum | 0−Is | Intestinal metaplasia | Foveolar hyperplasia + intestinal metaplasia | |
| 6 | 15 | Body** | Fibrosis | Gastritis + lymphoid
| ||
| 7 | 16 | Body | Intestinal metaplasia | Intestinal metaplasia | ||
| 17 | Antrum | Intestinal metaplasia | Intestinal metaplasia | |||
| 8 | 18 | 25 | Antrum | 0−IIa + IIc | Neoplasia | Well differentiated adenocarcinoma |
| 9 | 19 | 20 | Antrum*** | 0−Is | Hyperplastic polyp | Hyperplastic polyp |
| 10 | 20 | 20 | Antrum | 0−IIa + IIc | Neoplasia | Undifferentiated adenocarcinoma |